Allergen skin test reactivity and asthma are inversely associated with ratios of IgG4/IgE and total IgE/allergen-specific IgE in Ugandan communities.


Journal

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
ISSN: 1365-2222
Titre abrégé: Clin Exp Allergy
Pays: England
ID NLM: 8906443

Informations de publication

Date de publication:
05 2021
Historique:
revised: 12 11 2020
received: 15 07 2020
accepted: 22 01 2021
pubmed: 30 1 2021
medline: 3 2 2022
entrez: 29 1 2021
Statut: ppublish

Résumé

Serum inhibition of allergen-specific IgE has been associated with competing IgG4 and non-specific polyclonal IgE. In allergen immunotherapy, beneficial responses have been associated with high IgG4/IgE ratios. Helminths potentiate antibody class switching to IgG4 and stimulate polyclonal IgE synthesis; therefore, we hypothesized a role for helminth-associated IgG4 and total IgE in protection against atopic sensitization and clinical allergy (asthma) in tropical low-income countries. Among community residents of Ugandan rural Schistosoma mansoni (Sm)-endemic islands and a mainland urban setting with lower helminth exposure, and among urban asthmatic schoolchildren and non-asthmatic controls, we measured total, Schistosoma adult worm antigen (SWA)-specific, Schistosoma egg antigen (SEA)-specific and allergen (house dust mite [HDM] and German cockroach)-specific IgE and IgG4 by ImmunoCAP Total IgE, total IgG4 and SWA-, SEA- and allergen-specific IgE and IgG4 levels were significantly higher in the rural, compared to the urban setting. In both community settings, both Sm infection and SPT reactivity were positively associated with allergen-specific and total IgE responses. SPT reactivity was inversely associated with Schistosoma-specific IgG4, allergen-specific IgG4/IgE ratios and total IgE/allergen-specific IgE ratios. Asthmatic schoolchildren, compared with non-asthmatic controls, had significantly higher levels of total and allergen-specific IgE, but lower ratios of allergen-specific IgG4/IgE and total IgE/allergen-specific IgE. Our immuno-epidemiological data support the hypothesis that the IgG4-IgE balance and the total IgE-allergen-specific IgE balance are more important than absolute total, helminth- or allergen-specific antibody levels in inhibition of allergies in the tropics.

Sections du résumé

BACKGROUND
Serum inhibition of allergen-specific IgE has been associated with competing IgG4 and non-specific polyclonal IgE. In allergen immunotherapy, beneficial responses have been associated with high IgG4/IgE ratios. Helminths potentiate antibody class switching to IgG4 and stimulate polyclonal IgE synthesis; therefore, we hypothesized a role for helminth-associated IgG4 and total IgE in protection against atopic sensitization and clinical allergy (asthma) in tropical low-income countries.
METHODS
Among community residents of Ugandan rural Schistosoma mansoni (Sm)-endemic islands and a mainland urban setting with lower helminth exposure, and among urban asthmatic schoolchildren and non-asthmatic controls, we measured total, Schistosoma adult worm antigen (SWA)-specific, Schistosoma egg antigen (SEA)-specific and allergen (house dust mite [HDM] and German cockroach)-specific IgE and IgG4 by ImmunoCAP
RESULTS
Total IgE, total IgG4 and SWA-, SEA- and allergen-specific IgE and IgG4 levels were significantly higher in the rural, compared to the urban setting. In both community settings, both Sm infection and SPT reactivity were positively associated with allergen-specific and total IgE responses. SPT reactivity was inversely associated with Schistosoma-specific IgG4, allergen-specific IgG4/IgE ratios and total IgE/allergen-specific IgE ratios. Asthmatic schoolchildren, compared with non-asthmatic controls, had significantly higher levels of total and allergen-specific IgE, but lower ratios of allergen-specific IgG4/IgE and total IgE/allergen-specific IgE.
CONCLUSIONS AND CLINICAL RELEVANCE
Our immuno-epidemiological data support the hypothesis that the IgG4-IgE balance and the total IgE-allergen-specific IgE balance are more important than absolute total, helminth- or allergen-specific antibody levels in inhibition of allergies in the tropics.

Identifiants

pubmed: 33512036
doi: 10.1111/cea.13834
pmc: PMC7610822
mid: EMS124574
doi:

Substances chimiques

Allergens 0
Antigens, Dermatophagoides 0
Helminth Proteins 0
Immunoglobulin G 0
Insect Proteins 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

703-715

Subventions

Organisme : Wellcome Trust
ID : 102512
Pays : United Kingdom
Organisme : Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement
Organisme : Wellcome Trust
ID : 095778
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107743
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00027/5
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102512/Z/13/Z
Pays : United Kingdom
Organisme : African Partnership for Chronic Disease Research
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204928/Z/16/Z
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.

Références

Curr Top Microbiol Immunol. 2015;388:91-108
pubmed: 25553796
Clin Infect Dis. 2019 May 2;68(10):1665-1674
pubmed: 30202872
Am J Respir Crit Care Med. 2006 Sep 1;174(5):514-23
pubmed: 16778161
Trop Med Int Health. 2008 Feb;13(2):247-55
pubmed: 18304272
Clin Exp Allergy. 2001 Nov;31(11):1672-8
pubmed: 11696042
Eur J Immunol. 1992 Aug;22(8):2063-70
pubmed: 1639104
PLoS Negl Trop Dis. 2014 Sep 25;8(9):e3124
pubmed: 25254513
Pediatr Allergy Immunol. 2014 Aug;25(5):481-8
pubmed: 25171741
J Allergy Clin Immunol. 2003 May;111(5):947-51
pubmed: 12743556
J Immunol. 1997 Feb 1;158(3):1438-45
pubmed: 9013989
Pediatr Allergy Immunol. 2011 May;22(3):305-12
pubmed: 21255083
Clin Transl Allergy. 2013 Feb 01;3(1):3
pubmed: 23369181
J Immunol. 2012 Sep 15;189(6):2995-3006
pubmed: 22908332
Wellcome Open Res. 2019 Nov 5;4:168
pubmed: 32656365
PLoS Comput Biol. 2015 Oct 29;11(10):e1004546
pubmed: 26513360
J Allergy Clin Immunol. 2010 Jan;125(1):106-7
pubmed: 20109742
Lancet. 2000 Nov 18;356(9243):1723-7
pubmed: 11095260
Am J Trop Med Hyg. 2007 Oct;77(4):685-90
pubmed: 17978072
Rev Inst Med Trop Sao Paulo. 1972 Nov-Dec;14(6):397-400
pubmed: 4675644
Int Arch Allergy Immunol. 2001 Nov;126(3):231-8
pubmed: 11752881
J Allergy Clin Immunol. 2003 May;111(5):995-1000
pubmed: 12743563
Immunology. 2002 Jan;105(1):9-19
pubmed: 11849310
Immunity. 2018 Nov 20;49(5):801-818
pubmed: 30462997
Parasite Immunol. 2018 Jan;40(1):
pubmed: 29171863
Int Arch Allergy Appl Immunol. 1979;58(2):232-6
pubmed: 370030
Am J Respir Crit Care Med. 2003 Aug 1;168(3):313-7
pubmed: 12714349
Rev Soc Bras Med Trop. 2014 Nov-Dec;47(6):770-4
pubmed: 25626657
Prog Allergy. 1982;31:178-233
pubmed: 6183672
J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):217-21
pubmed: 9500755
Allergy. 2021 Jan;76(1):233-246
pubmed: 32568414
Parasite Immunol. 1993 Jan;15(1):5-9
pubmed: 8433853
Allergy. 2011 Jul;66 Suppl 95:28-30
pubmed: 21668848
Trials. 2015 Apr 23;16:187
pubmed: 25902705
J Immunol. 1999 Sep 1;163(5):2944-52
pubmed: 10453043
J Allergy Clin Immunol. 2011 Feb;127(2):479-86
pubmed: 21185070
Nature. 1976 Feb 12;259(5543):484-6
pubmed: 56711
J Immunol. 1992 May 1;148(9):2731-7
pubmed: 1573266
Infect Immun. 2005 Jul;73(7):4106-11
pubmed: 15972499
PLoS Negl Trop Dis. 2012;6(2):e1510
pubmed: 22347513
Expert Rev Respir Med. 2018 Sep;12(9):733-743
pubmed: 30084271
Clin Exp Allergy. 2019 May;49(5):663-676
pubmed: 30633850
Afr Health Sci. 2008 Dec;8(4):239-43
pubmed: 20589131
Curr Allergy Asthma Rep. 2016 Mar;16(3):23
pubmed: 26892721
Elife. 2019 Nov 15;8:
pubmed: 31729315
Asian Pac J Allergy Immunol. 2008 Jun-Sep;26(2-3):105-12
pubmed: 19054928
Trans R Soc Trop Med Hyg. 2008 Apr;102(4):367-73
pubmed: 18321545
Allergy. 2016 Aug;71(8):1156-69
pubmed: 26918891
Trans R Soc Trop Med Hyg. 2009 Apr;103(4):342-6
pubmed: 19195671
J Clin Invest. 2006 Mar;116(3):833-41
pubmed: 16498503
Infect Immun. 2010 Jul;78(7):3160-7
pubmed: 20404082
APMIS. 2018 Jun;126(6):459-476
pubmed: 29924455

Auteurs

Gyaviira Nkurunungi (G)

Immunomodulation and Vaccines Programme, Medical Research Council / Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.

Jacent Nassuuna (J)

Immunomodulation and Vaccines Programme, Medical Research Council / Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.

Harriet Mpairwe (H)

Immunomodulation and Vaccines Programme, Medical Research Council / Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Joyce Kabagenyi (J)

Immunomodulation and Vaccines Programme, Medical Research Council / Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.

Margaret Nampijja (M)

Immunomodulation and Vaccines Programme, Medical Research Council / Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.

Richard E Sanya (RE)

Immunomodulation and Vaccines Programme, Medical Research Council / Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
College of Health Sciences, Makerere University, Kampala, Uganda.

Emily L Webb (EL)

MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Alison M Elliott (AM)

Immunomodulation and Vaccines Programme, Medical Research Council / Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH